{
    "2018-04-06": [
        [
            {
                "time": "2018-04-15",
                "original_text": "High-Yield Stocks at Rock-Bottom Prices",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Stocks",
                        "Rock-Bottom",
                        "Prices"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "A Look at Enanta Pharmaceuticals’ Financial Performance",
                "features": {
                    "keywords": [
                        "Enanta",
                        "Pharmaceuticals",
                        "Financial",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "Analysts’ Ratings for Enanta Pharmaceuticals and Peers in April",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Ratings",
                        "Enanta",
                        "Pharmaceuticals",
                        "Peers",
                        "April"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-18",
                "original_text": "Biogen Cracks the Case With AbbVie for Humira Biosimilar",
                "features": {
                    "keywords": [
                        "Biogen",
                        "AbbVie",
                        "Humira",
                        "Biosimilar"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "iShares S&P 500 Growth ETF Experiences Big Outflow",
                "features": {
                    "keywords": [
                        "iShares",
                        "S&P 500",
                        "Growth",
                        "ETF",
                        "Outflow"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "AbbVie to Host First-Quarter 2018 Earnings Conference Call",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Earnings",
                        "Conference",
                        "Call"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-21",
                "original_text": "Cancer killer: Tampa’s ‘best-kept secret’ M2Gen collects data from labs and bedsides to help target treatments",
                "features": {
                    "keywords": [
                        "Cancer",
                        "killer",
                        "Tampa",
                        "M2Gen",
                        "data",
                        "labs",
                        "bedsides",
                        "treatments"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-22",
                "original_text": "[$$] Samsung, Biogen Reach Deal With AbbVie to Sell Near Copy of Humira",
                "features": {
                    "keywords": [
                        "Samsung",
                        "Biogen",
                        "AbbVie",
                        "Humira",
                        "Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}